Genetic Technologies Alpha and Beta Analysis
| GENEDelisted Stock | USD 0.77 0.00 0.00% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Genetic Technologies. It also helps investors analyze the systematic and unsystematic risks associated with investing in Genetic Technologies over a specified time horizon. Remember, high Genetic Technologies' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Genetic Technologies' market risk premium analysis include:
Beta 0.0 | Alpha 0.0 | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Genetic |
Genetic Technologies Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Genetic Technologies market risk premium is the additional return an investor will receive from holding Genetic Technologies long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Genetic Technologies. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Genetic Technologies' performance over market.| α | 0.00 | β | 0.00 |
Genetic Technologies Fundamentals Vs Peers
Comparing Genetic Technologies' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Genetic Technologies' direct or indirect competition across all of the common fundamentals between Genetic Technologies and the related equities. This way, we can detect undervalued stocks with similar characteristics as Genetic Technologies or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Genetic Technologies' fundamental indicators could also be used in its relative valuation, which is a method of valuing Genetic Technologies by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Genetic Technologies to competition |
| Fundamentals | Genetic Technologies | Peer Average |
| Return On Equity | -1.85 | -0.31 |
| Return On Asset | -0.63 | -0.14 |
| Profit Margin | (1.24) % | (1.27) % |
| Operating Margin | (1.13) % | (5.51) % |
| Current Valuation | 3.44 M | 16.62 B |
| Shares Outstanding | 4.85 M | 571.82 M |
| Shares Owned By Institutions | 1.87 % | 39.21 % |
Genetic Technologies Opportunities
Genetic Technologies Return and Market Media
The Stock did not receive any noticable media coverage during the period. Price Growth (%) |
| Timeline |
About Genetic Technologies Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Genetic or other delisted stocks. Alpha measures the amount that position in Genetic Technologies has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Genetic Technologies Upcoming Company Events
As portrayed in its financial statements, the presentation of Genetic Technologies' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Genetic Technologies' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Genetic Technologies' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Genetic Technologies. Please utilize our Beneish M Score to check the likelihood of Genetic Technologies' management manipulating its earnings.
| 29th of August 2023 Upcoming Quarterly Report | View | |
| 30th of June 2023 Next Fiscal Quarter End | View |
Build Portfolio with Genetic Technologies
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Consideration for investing in Genetic Stock
If you are still planning to invest in Genetic Technologies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Genetic Technologies' history and understand the potential risks before investing.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |